The Oncology Institute Stock Price Prediction
| TOIIW Stock | USD 0.01 0 20.00% |
Oversold Vs Overbought
40
Oversold | Overbought |
Quarterly Revenue Growth 0.229 |
Using Oncology Institute hype-based prediction, you can estimate the value of The Oncology Institute from the perspective of Oncology Institute response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Oncology Institute to buy its stock at a price that has no basis in reality. In that case, they are not buying Oncology because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Oncology Institute after-hype prediction price | USD 0.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Oncology |
Oncology Institute After-Hype Price Prediction Density Analysis
As far as predicting the price of Oncology Institute at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Oncology Institute or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Oncology Institute, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Oncology Institute Estimiated After-Hype Price Volatility
In the context of predicting Oncology Institute's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Oncology Institute's historical news coverage. Oncology Institute's after-hype downside and upside margins for the prediction period are 0.00 and 17.76, respectively. We have considered Oncology Institute's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Oncology Institute is out of control at this time. Analysis and calculation of next after-hype price of The Oncology Institute is based on 3 months time horizon.
Oncology Institute Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Oncology Institute is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Oncology Institute backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Oncology Institute, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.82 | 17.75 | 0.00 | 0.03 | 4 Events / Month | 2 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 0.00 |
|
Oncology Institute Hype Timeline
The Oncology Institute is at this time traded for 0.01. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Oncology is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.82%. %. The volatility of related hype on Oncology Institute is about 42241.79%, with the expected price after the next announcement by competition of -0.02. The company recorded a loss per share of 602.09. The Oncology Institute had not issued any dividends in recent years. Assuming the 90 days horizon the next forecasted press release will be in about 4 days. Check out Oncology Institute Basic Forecasting Models to cross-verify your projections.Oncology Institute Related Hype Analysis
Having access to credible news sources related to Oncology Institute's direct competition is more important than ever and may enhance your ability to predict Oncology Institute's future price movements. Getting to know how Oncology Institute's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Oncology Institute may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TOI | Oncology Institute | (0.04) | 11 per month | 0.00 | (0.03) | 11.54 | (10.00) | 39.32 | |
| PIIIW | P3 Health Partners | 0.00 | 3 per month | 0.00 | (0.05) | 30.67 | (43.60) | 146.05 | |
| TALKW | Talkspace | 0.04 | 6 per month | 8.05 | 0.18 | 18.18 | (13.33) | 86.12 | |
| SRZNW | Surrozen Warrant | (0.0001) | 2 per month | 18.91 | 0.16 | 84.00 | (48.50) | 196.04 | |
| ROIVW | Roivant Sciences | (0.21) | 2 per month | 4.20 | 0.10 | 8.80 | (7.03) | 24.42 |
Oncology Institute Additional Predictive Modules
Most predictive techniques to examine Oncology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oncology using various technical indicators. When you analyze Oncology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Oncology Institute Predictive Indicators
The successful prediction of Oncology Institute stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as The Oncology Institute, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Oncology Institute based on analysis of Oncology Institute hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Oncology Institute's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Oncology Institute's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.0265 | 0.0235 | Price To Sales Ratio | 0.46 | 0.44 |
Story Coverage note for Oncology Institute
The number of cover stories for Oncology Institute depends on current market conditions and Oncology Institute's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Oncology Institute is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Oncology Institute's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Oncology Institute Short Properties
Oncology Institute's future price predictability will typically decrease when Oncology Institute's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of The Oncology Institute often depends not only on the future outlook of the potential Oncology Institute's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oncology Institute's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 73.7 M | |
| Cash And Short Term Investments | 82.9 M |
Additional Tools for Oncology Stock Analysis
When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.